Home -> Law Blog Directory -> Patent Law Blogs -> Philip Brooks’ Patent Infringement Updates
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Philip Brooks’ Patent Infringement UpdatesEstimating Damages of Patent Infringement Seminar
By Philip Brooks
Incremental Advantage will host the above-titled conference in Washington, DC and via webinar:
Patent damages are outlined in the 35 USC § 284 statute and state that a patent holder is entitled to at least a reasonable royalty as damages. This code also defines the compensatory nature of patent damages and allows for any damages necessary to adequately compensate the patent holder. The compensatory damages can include lost profits, price erosion, harm to company?s reputation, harm to company?s relationships with its customers and suppliers, and so on (besides a reasonable royalty).
This course is designed to address the issues that arise in the determination of reasonable royalty damages. We start with the basics of how to determine a reasonable royalty including:
> The Georgia-Pacific factors
- Rates for other similar patents
- Nature and scope of license
- Commercial relationships
- Duration of patent and term of license
- Extent of infringer use of invention
- Other
> Cost of next best alternatives
> Milestone payments
This course will also discuss how to determine the lost sales and associated lost profits using incremental costs approach. It will look into methods used to assess price erosion and other economic harms to the patent holder. Note, patent damages do not allow for disgorgement of the infringer?s profit unless it is a design patent.
This course will be held on:
- Washington DC - January 28, 2010
- Webinar - January 28, 2010
- Webinar - March 23, 2010
Click here for more information, schedule of dates and times and to register!
Full post as published by Philip Brooks’ Patent Infringement Updates on January 25, 2010 (boomark / email).
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
The Princeton Review
$2.6 million settlement reached in patent infringement case.
Underground Piping
Insituform Technologies awarded $4.5 million patent infringement settlement.
DNA Products
Agilent Technologies pays undisclosed patent infringement settlement to Invitrogen Corporation.

Negotiating Patent Infringement Settlements
Leadership liability: Protecting directors, officers from exposure to patent infringement damages
The US Federal Trade Commission considers issues in patent damages awards
Would Apportionment of Damages Adversely Effect Patents
Some (But Not All) Amendments Introduced in "Patent Reform" Bill








